Bee and Frog Proteins: Nature’s Double Defense Against Farm Superbugs
en-GBde-DEes-ESfr-FR

Bee and Frog Proteins: Nature’s Double Defense Against Farm Superbugs


A new study reveals that combining natural antimicrobial peptides can significantly slow the development of antimicrobial resistance in bacteria. The research shows that using two peptides together prevents harmful bacteria from mutating as quickly, offering a promising alternative to traditional antibiotics. These findings could lead to safer, more sustainable disease control in livestock and agricultural settings.

Antibiotic resistance isn’t just a hospital problem—it’s a growing threat on the farm, too. From poultry barns to dairy sheds, the overuse of antibiotics in agriculture has given rise to “superbugs” that endanger animals, crops, and even human health. But what if the solution has been buzzing and hopping around us all along?

In a new study led by Bar Maron, a joint PhD student, in collaboration with Prof. Jonathan Friedman and Prof. Zvi Hayouka from the Faculty of Agriculture, Food and Environment at the Hebrew University of Jerusalem, scientists have discovered that antimicrobial peptides (AMPs)—tiny proteins that are part of the immune system of almost all organisms—can work together to block the development of bacterial resistance.

“Bacteria are smart. When you hit them with one weapon, they often find a way around it,” says Prof. Hayouka. “But when we used two peptides at once, it was like closing all the escape routes.”

The research, published in iScience, focused on Staphylococcus aureus, a significant pathogen responsible for persistent infections in animals and humans alike. Using three AMPs—melittin (from bees), temporin (from frogs), and pexiganan (a synthetic peptide inspired by nature)—the team watched how bacteria evolved over time. The results were significant: when bacteria were exposed to a single peptide, they quickly developed resistance through genetic mutations. But when two peptides were combined? The bacteria were stumped, mutating less and staying vulnerable.

This could be an important advancement for agriculture, where antibiotic resistance has already begun to affect livestock health and farmer livelihoods.
By reducing reliance on synthetic antibiotics and turning to natural peptide combinations, the industry could move toward safer, more sustainable ways of managing disease.

“These peptides are part of nature’s own defense system. Animals have been using them for millions of years,” says Prof. Friedman. “By borrowing from nature and using them wisely, we can tip the scales back in our favor.”

The findings could pave the way for new feed additives or topical treatments that keep infections in check without triggering resistance. It also offers hope for maintaining herd health without contributing to the global AMR (antimicrobial resistance) crisis.

Of course, more research is needed before these peptides make their way into farm protocols. But the message is clear: when it comes to fighting superbugs, sometimes two peptides are better than one.
The research paper titled “Uncovering the genetic basis of Staphylococcus aureus resistance to single antimicrobial peptides and their combinations” is now available in iScience and can be accessed at https://doi.org/10.1016/j.isci.2025.112671.
Researchers:
Bar Maron 1 2, Caroline Zanchi 3, Paul Johnston 4, Jens Rolff 3, Jonathan Friedman 2, Zvi Hayouka 1
Institutions:
1) Institute of Biochemistry, Food Science and Nutrition, The Hebrew University of Jerusalem, Rehovot, Israel
2) Institute of Environmental Sciences, The Hebrew University of Jerusalem, Rehovot, Israel
3) Institute of Biology, Evolutionary Biology, Freie Universität, Berlin, Germany
4) University of St Andrews, School of Medicine, North Haugh, KY16 9TF St Andrews, UK
Archivos adjuntos
  • Figure Name: Combating Bacterial Resistance with Peptide CombinationsFigure Description: The figure illustrates a key strategy to prevent the evolution of antimicrobial resistance. When bacteria are treated with a single antimicrobial peptide (AMP)—from a source like a honeybee (top) or a frog (bottom)—they can rapidly evolve resistance, which renders the treatment ineffective. However, when the bacteria are treated with a combination of different AMPs, they are effectively killed (center), and their ability to evolve resistance is significantly hindered. This approach makes peptide combinations a promising strategy for developing more durable, 'resistance-proof' therapies.Credit: Bar Maron, The Hebrew University of Jerusalem, the figure created with Biorender.com
Regions: Middle East, Israel, Europe, United Kingdom, North America, United States
Keywords: Science, Chemistry, Life Sciences

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Testimonios

We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet
AlphaGalileo is a great source of global research news. I use it regularly.
Robert Lee Hotz, LA Times

Trabajamos en estrecha colaboración con...


  • e
  • The Research Council of Norway
  • SciDevNet
  • Swiss National Science Foundation
  • iesResearch
Copyright 2025 by DNN Corp Terms Of Use Privacy Statement